Dose-response of ropivacaine administered caudally to children undergoing surgical procedures under sedation with midazolam

Clinical and Experimental Pharmacology and Physiology

Volumn 31, Issue 7, 2004, Pages 462-465

  Tonatiu Aguirre Garay, F ^a   García, Rosario ^b   Nava Ocampo, Alejandro A ^c  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Centro Médico de León   (Mexico)

^c HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

Author keywords

Drug dose response relationship; Local anaesthetics; Postoperative pain; Regional anaesthesia

Indexed keywords

ATROPINE; BUPIVACAINE; MIDAZOLAM; ROPIVACAINE; SEVOFLURANE;

ARTICLE; CARDIOVASCULAR RESPONSE; CAUDAL ANESTHESIA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; OPERATION DURATION; PEDIATRIC SURGERY; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; RANDOMIZED CONTROLLED TRIAL; SEDATION; SYSTOLIC BLOOD PRESSURE; VOMITING;

AMIDES; ANESTHESIA, SPINAL; ANESTHETICS, LOCAL; BUPIVACAINE; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; LINEAR MODELS; MALE; MIDAZOLAM; PAIN MEASUREMENT;

EID: 3843079731     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2004.04020.x     Document Type: Article

References (26)

1. Caims C. Caudal anaesthesia in neonates and infants. Anaesthesia 1980; 35: 1136-7.
2. Yaster M, Maxwell LG. Pediatric regional anesthesia. Anesthesiology 1989; 70: 324-38.
3. Brown DL, Ransom DM, Hall JA, Leicht CH, Schroeder DR, Offord KP. Regional anesthesia and local anesthetic-induced systemic toxicity. Seizure frequency and accompanying cardiovascular changes. Anesth. Analg. 1995; 81: 321-8.
4. McCloskey JJ, Haun SE, Deshpande JK. Bupivacaine toxicity secondary to continuous caudal epidural infusion in children. Anesth. Analg. 1992; 75: 287-90.
5. Freid EB, Bailey AG, Valley RD. Electrocardiographic and hemodynamic changes associated with unintentional intravascular injection of bupivacaine with epinephrine in infants. Anesthesiology 1993; 79: 394-8.
6. Ved SA, Pinosky M, Nicodemus H. Ventricular tachycardia and brief cardiovascular collapse in two infants after caudal anesthesia using a bupivacaine-epinephrine solution. Anesthesiology 1993; 79: 1121-3.
7. Agarwal R, Gutlove DP, Lockhart CH. Seizures occurring in pediatric patients receiving continuous infusion of bupivacaine. Anesth. Analg. 1992; 75: 284-6.
8. McGown RG. Caudal analgesia, in children. Five hundred cases for procedures below the diaphragm. Anaesthesia 1982; 37: 806-18.
9. Da Conceicao MJ, Coelho L. Caudal anaesthesia with 0.375% ropivacaine or 0.375% bupivacaine in paediatric patients. Br. J. Anaesth. 1998; 80: 507-8.
10. Da Conceicao MJ, Coelho L, Khalil M. Ropivacaine 0.25% compared with bupivacaine 0.25% by the caudal route. Paediatr. Anaesth. 1999; 9: 229-33.
11. Sanders JC. Paediatric regional anaesthesia, a survey of practice in the United Kingdom. Br. J. Anaesth. 2002; 89: 707-10.
12. Moyao-García D, Corrales-Fernández MA, Blanco- Rodríguez G, Sánchez-Hernández E, Nava-Ocampo AA. Benefits of oral administration of an electrolyte solution interrupting a prolonged preoperatory fasting period in pediatric patients. J. Pediatr. Surg. 2001; 36: 457-9.
13. -1) of bupivacaine 0.25% in children undergoing surgical correction of congenital pyloric stenosis. Paediatr. Anaesth. 2002; 12: 404-10.
14. Melman E, Arenas JA, Tandazo WE. Caudal anesthesia for pediatric surgery. An easy method for calculating dose requirements. Anesthesiology 1985; 63: A439 (Abstract).
15. Broadman L, Rice L, Hannallah R. Evaluation of an objective pain scale for infants and children. Reg. Anesth. 1988; 13: 45.
16. Luz G, Innerhofer P, Haussler B, Oswald E, Salner E, Sparr H. Comparison of ropivacaine 0.1% and 0.2% with bupivacaine 0.2% for single-shot caudal anaesthesia in children. Paediatr. Anaesth. 2000; 10: 499-504.
17. Koinig H, Krenn C, Glaser C et al. The dose-response of caudal ropivacaine in children. Anesthesiology 1999; 90: 1339-44.
18. Ivani G, Lampugnani E, Torre M et al. Comparison of ropivacaine with bupivacaine for paediatric caudal block. Br. J. Anaesth. 1998; 81: 247-8.
19. Ivani G, DeNegri P, Conio A et al. Comparison of racemic bupivacaine, ropivacaine, and levo-bupivacaine for pediatric caudal anesthesia: Effects on postoperative analgesia and motor block. Reg. Anesth. Pain Med. 2002; 27: 157-61.
20. Khalil S, Campos C, Farag AM, Vije H, Ritchey M, Chuang A. Caudal block in children: Ropivacaine compared with bupivacaine. Anesthesiology 1999; 91: 1279-84.
21. Nava-Ocampo AA, Bello-Ramírez AM. Lipophilicity affects the pharmacokinetics and toxicity of local anesthetic agents administered by caudal block. Clin. Exp. Pharmacol. Physiol. 2004; 31: 116-18.
22. Blumer JL. Clinical pharmacology of midazolam in infants and children. Clin. Pharmacokinet. 1998; 35: 37-47.
23. Oda Y, Furuichi K, Tanaka K et al. Metabolism of a new local anesthetic, ropivacaine, by human hepatic cytochrome P450. Anesthesiology 1995; 82: 214-20.
24. Ekström G, Gunnarsson UB. Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P4501A and 3A in human liver microsomes. Drug Metab. Dispos. 1996; 24: 955-61.
25. Halldin MM, Bredberg E, Angelin B et al. Metabolism and excretion of ropivacaine in humans. Drug Metab. Dispos. 1996; 24: 962-8.
26. -1) vs general anaesthesia with fentanyl for cardiac surgery. Paediatr. Anaesth. 2003; 13: 311-17.